Bringing a prophylactic Ebola vaccine to licensure

Información del proyecto

EBOVAC3

Identificador del acuerdo de subvención: 800176

DOI

10.3030/800176

Proyecto cerrado

Fecha de la firma de la CE 15 Junio 2018

Fecha de inicio 1 Junio 2018

Fecha de finalización 30 Septiembre 2024

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total

€ 50 979 889,71

Aportación de la UE

€ 29 402 655,71

Coordinado por

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
United Kingdom

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (2)

Pilot on integrated solution linking vaccine label to biometric profile
Communication tools and brand identity: key messaging documents, project website, flyer, core presentations

Publicaciones

Other (4)

Safety and immunogenicity of the heterologous two-dose Ad26.ZEBOV, MVA-BN-Filo vaccine regimen in healthcare providers and frontliners of the Democratic Republic of the Congo.

Autores: Y Larivière, I Garcia-Fogeda, T Zola Matuvanga et al.
Publicado en: 2023
Editor: UAntwerp / UNIKIN
DOI: 10.1093/infdis/jiad350

Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: An optimal control approach

Autores: Clairon, Quentin; Pasin, Chloé; Balelli, Irene; Thiébaut, Rodolphe; Prague, Mélanie
Publicado en: HAL Open Science, Edición 1, 2021
Editor: HAL Open Science
DOI: 10.13140/rg.2.2.18016.81920

Researchers’ responsibility in low-resource settings: experiences of an ancillary care policy and practices in a vaccine trial in the Democratic Republic of the Congo

Autores: Gwen Lemey, T Zola Matuvanga, Ynke Larivière, Solange Milolo, Engbu Danoff, Lazarre Bakonga, Emmanuel Esanga, Peter Vermeiren, Vivi Maketa, Junior Matangila, Patrick Mitashi, Pierre Van Damme, Jean-Pierre Van geertruyden , Raffaella Ravinetto, Hypolite Muhindo-Mavoko
Publicado en: Research Ethics, 2023
Editor: UAntwerp
DOI: 10.1177/17470161231194139

Rapport final Etude de la résurgence de la Maladie à Virus Ébola dans la région de Nzérékoré par l’équipe du CERFIG-RKI-IRD-UNICEF

Autores: Saez, Almudena Mari, Frederic Le Marcis et al.
Publicado en: 2021
Editor: Institute of Research for Development
DOI: 10.13140/rg.2.2.14143.84641

Peer reviewed articles (6)

Setting up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned

Autores: Trésor Zola Matuvanga, Ynke Larivière, Gwen Lemey, Jessie De Bie , Solange Milolo, Rachel Meta, Emmanuel Esanga, Paul Peter Vermeiren , Séverine Thys, Jean-Pierre Van geertruyden , Pierre Van Damme, Vivi Maketa, Junior Matangila , Patrick Mitashi, Hypolite Muhindo-Mavoko
Publicado en: Vaccine, 2022, ISSN 0264-410X
Editor: Elsevier BV
DOI: 10.1016/j.vaccine.2022.04.094

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Autores: Zola Matuvanga T, Johnson G, Larivière Y, Esanga Longomo E, Matangila J, Maketa V, Lapika B, Mitashi P, Mc Kenna P, De Bie J, Van Geertruyden J, Van Damme P, Muhindo Mavoko H.
Publicado en: Journal of Medical Internet Research, 2021, ISSN 1438-8871
Editor: Journal of medical Internet Research
DOI: 10.2196/28573

Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo

Autores: Lemey, Gwen, Ynke Larivière, Trésor Zola, Hypolite Muhindo, Vivi Maketa, Patrick Mitashi, Junior Matangila, Peter Vermeiren, Jessie De Bie, Jean-Pierre Van geertruyden, Pierre Van Damme
Publicado en: BMJ Global Health, 2021, ISSN 2059-7908
Editor: BMJ Global Health
DOI: 10.1136/bmjgh-2021-005726

Resurgence of Ebola Virus in 2021 in Guinea Suggests a New Paradigm for Outbreaks

Autores: Keita, Alpha Kabinet, Fara R. Koundouno, Martin Faye, Ariane Düx, Julia Hinzmann, Haby Diallo, Ahidjo Ayouba, Le Marcis, Frédéric et al. 2021.
Publicado en: Nature, 2021, ISSN 1476-4687
Editor: Nature
DOI: 10.1038/s41586-021-03901-9

Potential Test-Negative Design Study Bias in Outbreak Settings: Application to Ebola vaccination in Democratic Republic of Congo

Autores: Carl B Pearson, W John Edmunds, Thomas J Hladish, Rosalind M Eggo
Publicado en: International Journal of Epidemiology, 2022, ISSN 0300-5771
Editor: Oxford University Press
DOI: 10.1093/ije/dyab172

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol

Autores: Ynke Larivière, Trésor Zola, Elke Stoppie, Vivi Maketa, Junior Matangila, Patrick Mitashi, Jessie De Bie, Hypolite Muhindo, Jean-Pierre Van geertruyden, Pierre Van Damme
Publicado en: BMJ Open, 2021, ISSN 2044-6055
Editor: BMJ Publishing Group
DOI: 10.1136/bmjopen-2020-046835